Estrogen receptors as the novel therapeutic biomarker in non-small cell lung cancer
{{output}}
Although a wide range of studies have addressed the relationship between estrogen receptor (ER) expression and prognosis in non-small cell lung cancer (NSCLC), that relationship remains controversial. This is in large part because there is no consensus on the ... ...
